HEADER TRANSFERASE 18-JAN-16 5HNI TITLE CRYSTAL STRUCTURE OF CMET WT WITH COMPOUND 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: X, Y; COMPND 4 FRAGMENT: UNP RESIDUES 1067-1378; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.VALLEE,J.HOUTMANN REVDAT 3 08-MAY-24 5HNI 1 REMARK REVDAT 2 16-OCT-19 5HNI 1 REMARK REVDAT 1 23-NOV-16 5HNI 0 JRNL AUTH A.UGOLINI,M.KENIGSBERG,A.RAK,F.VALLEE,J.HOUTMANN,M.LOWINSKI, JRNL AUTH 2 C.CAPDEVILA,J.KHIDER,E.ALBERT,N.MARTINET,C.NEMECEK, JRNL AUTH 3 S.GRAPINET,E.BACQUE,M.ROESNER,C.DELAISI,L.CALVET,F.BONCHE, JRNL AUTH 4 D.SEMIOND,C.EGILE,H.GOULAOUIC,L.SCHIO JRNL TITL DISCOVERY AND PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES JRNL TITL 2 OF THE POTENT AND SELECTIVE MET KINASE INHIBITOR JRNL TITL 3 1-{6-[6-(4-FLUOROPHENYL)-[1,2,4]TRIAZOLO[4, JRNL TITL 4 3-B]PYRIDAZIN-3-YLSULFANYL]BENZOTHIAZOL-2-YL}-3-(2-MORPHOLIN JRNL TITL 5 -4-YLETHYL)UREA (SAR125844). JRNL REF J.MED.CHEM. V. 59 7066 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27355974 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00280 REMARK 2 REMARK 2 RESOLUTION. 1.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 77.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 77.1 REMARK 3 NUMBER OF REFLECTIONS : 50994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3904 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 379 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HNI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-SEP-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50994 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.710 REMARK 200 RESOLUTION RANGE LOW (A) : 77.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 77.1 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES 100MM, ISOPROPANOL 11%, PEG5000 REMARK 280 MME 6%, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: Y REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN X 1049 REMARK 465 THR X 1050 REMARK 465 VAL X 1051 REMARK 465 HIS X 1052 REMARK 465 ILE X 1053 REMARK 465 ASP X 1054 REMARK 465 LEU X 1055 REMARK 465 SER X 1056 REMARK 465 ALA X 1057 REMARK 465 LEU X 1058 REMARK 465 ASN X 1059 REMARK 465 PRO X 1060 REMARK 465 GLU X 1061 REMARK 465 LEU X 1062 REMARK 465 SER X 1074 REMARK 465 SER X 1075 REMARK 465 LEU X 1076 REMARK 465 ILE X 1077 REMARK 465 VAL X 1078 REMARK 465 HIS X 1079 REMARK 465 PHE X 1080 REMARK 465 ASN X 1081 REMARK 465 GLU X 1082 REMARK 465 VAL X 1083 REMARK 465 ILE X 1084 REMARK 465 GLY X 1085 REMARK 465 ARG X 1086 REMARK 465 GLY X 1087 REMARK 465 HIS X 1088 REMARK 465 PHE X 1089 REMARK 465 LEU X 1098 REMARK 465 ASP X 1099 REMARK 465 ASN X 1100 REMARK 465 ASP X 1101 REMARK 465 GLY X 1102 REMARK 465 LYS X 1103 REMARK 465 LEU X 1112 REMARK 465 ASN X 1113 REMARK 465 ARG X 1114 REMARK 465 ILE X 1115 REMARK 465 THR X 1116 REMARK 465 ASP X 1117 REMARK 465 ILE X 1118 REMARK 465 GLY X 1119 REMARK 465 GLU X 1120 REMARK 465 ASP X 1231 REMARK 465 LYS X 1232 REMARK 465 GLU X 1233 REMARK 465 PHE X 1234 REMARK 465 ASP X 1235 REMARK 465 SER X 1236 REMARK 465 VAL X 1237 REMARK 465 HIS X 1238 REMARK 465 ASN X 1239 REMARK 465 LYS X 1240 REMARK 465 THR X 1241 REMARK 465 GLY X 1242 REMARK 465 ALA X 1243 REMARK 465 LYS X 1244 REMARK 465 LEU X 1245 REMARK 465 PRO X 1246 REMARK 465 VAL X 1247 REMARK 465 LYS X 1248 REMARK 465 VAL X 1357 REMARK 465 ASN X 1358 REMARK 465 VAL X 1359 REMARK 465 LYS X 1360 REMARK 465 ASN Y 1049 REMARK 465 THR Y 1050 REMARK 465 VAL Y 1051 REMARK 465 HIS Y 1052 REMARK 465 ILE Y 1053 REMARK 465 ASP Y 1054 REMARK 465 LEU Y 1055 REMARK 465 SER Y 1056 REMARK 465 ALA Y 1057 REMARK 465 LEU Y 1058 REMARK 465 ASN Y 1059 REMARK 465 PRO Y 1060 REMARK 465 GLU Y 1061 REMARK 465 LEU Y 1062 REMARK 465 SER Y 1074 REMARK 465 SER Y 1075 REMARK 465 LEU Y 1076 REMARK 465 ILE Y 1077 REMARK 465 VAL Y 1078 REMARK 465 HIS Y 1079 REMARK 465 PHE Y 1080 REMARK 465 ASN Y 1081 REMARK 465 GLU Y 1082 REMARK 465 VAL Y 1083 REMARK 465 ILE Y 1084 REMARK 465 GLY Y 1085 REMARK 465 ARG Y 1086 REMARK 465 GLY Y 1087 REMARK 465 HIS Y 1088 REMARK 465 PHE Y 1089 REMARK 465 LEU Y 1098 REMARK 465 ASP Y 1099 REMARK 465 ASN Y 1100 REMARK 465 ASP Y 1101 REMARK 465 GLY Y 1102 REMARK 465 LYS Y 1103 REMARK 465 LEU Y 1112 REMARK 465 ASN Y 1113 REMARK 465 ARG Y 1114 REMARK 465 ILE Y 1115 REMARK 465 THR Y 1116 REMARK 465 ASP Y 1117 REMARK 465 ILE Y 1118 REMARK 465 GLY Y 1119 REMARK 465 GLU Y 1120 REMARK 465 ASP Y 1231 REMARK 465 LYS Y 1232 REMARK 465 GLU Y 1233 REMARK 465 PHE Y 1234 REMARK 465 ASP Y 1235 REMARK 465 SER Y 1236 REMARK 465 VAL Y 1237 REMARK 465 HIS Y 1238 REMARK 465 ASN Y 1239 REMARK 465 LYS Y 1240 REMARK 465 THR Y 1241 REMARK 465 GLY Y 1242 REMARK 465 ALA Y 1243 REMARK 465 LYS Y 1244 REMARK 465 LEU Y 1245 REMARK 465 PRO Y 1246 REMARK 465 VAL Y 1247 REMARK 465 LYS Y 1248 REMARK 465 VAL Y 1357 REMARK 465 ASN Y 1358 REMARK 465 VAL Y 1359 REMARK 465 LYS Y 1360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR X1356 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR Y1356 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR X1126 -74.13 -61.74 REMARK 500 SER X1149 78.61 -153.66 REMARK 500 ARG X1203 -22.83 85.10 REMARK 500 ASP X1204 49.18 -141.87 REMARK 500 ALA X1221 -162.75 -128.77 REMARK 500 ALA X1226 33.40 -86.79 REMARK 500 ALA Y1065 35.35 -92.44 REMARK 500 VAL Y1066 20.87 -146.76 REMARK 500 SER Y1149 71.71 -153.86 REMARK 500 SER Y1152 -34.73 -168.33 REMARK 500 ARG Y1203 -19.62 88.30 REMARK 500 ASP Y1204 47.26 -140.76 REMARK 500 ALA Y1221 -162.90 -128.60 REMARK 500 LEU Y1225 30.26 -90.63 REMARK 500 ASP Y1228 170.04 177.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH X1693 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH X1694 DISTANCE = 6.37 ANGSTROMS REMARK 525 HOH Y1685 DISTANCE = 6.36 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 63B X 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 63B Y 1401 DBREF 5HNI X 1049 1360 UNP P08581 MET_HUMAN 1067 1378 DBREF 5HNI Y 1049 1360 UNP P08581 MET_HUMAN 1067 1378 SEQADV 5HNI PHE X 1194 UNP P08581 TYR 1212 CONFLICT SEQADV 5HNI PHE X 1234 UNP P08581 TYR 1252 CONFLICT SEQADV 5HNI ASP X 1235 UNP P08581 TYR 1253 CONFLICT SEQADV 5HNI PHE Y 1194 UNP P08581 TYR 1212 CONFLICT SEQADV 5HNI PHE Y 1234 UNP P08581 TYR 1252 CONFLICT SEQADV 5HNI ASP Y 1235 UNP P08581 TYR 1253 CONFLICT SEQRES 1 X 312 ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU SEQRES 2 X 312 LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SEQRES 3 X 312 SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY SEQRES 4 X 312 HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN SEQRES 5 X 312 ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN SEQRES 6 X 312 ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR SEQRES 7 X 312 GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL SEQRES 8 X 312 LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER SEQRES 9 X 312 PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU SEQRES 10 X 312 ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL SEQRES 11 X 312 LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY SEQRES 12 X 312 MET LYS PHE LEU ALA SER LYS LYS PHE VAL HIS ARG ASP SEQRES 13 X 312 LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR SEQRES 14 X 312 VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR SEQRES 15 X 312 ASP LYS GLU PHE ASP SER VAL HIS ASN LYS THR GLY ALA SEQRES 16 X 312 LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN SEQRES 17 X 312 THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER PHE SEQRES 18 X 312 GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO SEQRES 19 X 312 PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR SEQRES 20 X 312 LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS SEQRES 21 X 312 PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS SEQRES 22 X 312 PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SEQRES 23 X 312 SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU SEQRES 24 X 312 HIS TYR VAL HIS VAL ASN ALA THR TYR VAL ASN VAL LYS SEQRES 1 Y 312 ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU SEQRES 2 Y 312 LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SEQRES 3 Y 312 SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY SEQRES 4 Y 312 HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN SEQRES 5 Y 312 ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN SEQRES 6 Y 312 ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR SEQRES 7 Y 312 GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL SEQRES 8 Y 312 LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER SEQRES 9 Y 312 PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU SEQRES 10 Y 312 ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL SEQRES 11 Y 312 LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY SEQRES 12 Y 312 MET LYS PHE LEU ALA SER LYS LYS PHE VAL HIS ARG ASP SEQRES 13 Y 312 LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR SEQRES 14 Y 312 VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR SEQRES 15 Y 312 ASP LYS GLU PHE ASP SER VAL HIS ASN LYS THR GLY ALA SEQRES 16 Y 312 LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN SEQRES 17 Y 312 THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER PHE SEQRES 18 Y 312 GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO SEQRES 19 Y 312 PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR SEQRES 20 Y 312 LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS SEQRES 21 Y 312 PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS SEQRES 22 Y 312 PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SEQRES 23 Y 312 SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU SEQRES 24 Y 312 HIS TYR VAL HIS VAL ASN ALA THR TYR VAL ASN VAL LYS HET 63B X1401 31 HET 63B Y1401 31 HETNAM 63B METHYL (6-{[6-(4-FLUOROPHENYL)[1,2,4]TRIAZOLO[4,3- HETNAM 2 63B B]PYRIDAZIN-3-YL]SULFANYL}-1H-BENZIMIDAZOL-2-YL) HETNAM 3 63B CARBAMATE FORMUL 3 63B 2(C20 H14 F N7 O2 S) FORMUL 5 HOH *379(H2 O) HELIX 1 AA1 GLN X 1123 PHE X 1134 1 12 HELIX 2 AA2 ASP X 1164 ASN X 1171 1 8 HELIX 3 AA3 THR X 1177 LYS X 1198 1 22 HELIX 4 AA4 ALA X 1206 ARG X 1208 5 3 HELIX 5 AA5 PHE X 1223 ARG X 1227 5 5 HELIX 6 AA6 ALA X 1251 GLN X 1258 1 8 HELIX 7 AA7 THR X 1261 THR X 1278 1 18 HELIX 8 AA8 ASN X 1288 PHE X 1290 5 3 HELIX 9 AA9 ASP X 1291 GLN X 1298 1 8 HELIX 10 AB1 PRO X 1309 TRP X 1320 1 12 HELIX 11 AB2 LYS X 1323 ARG X 1327 5 5 HELIX 12 AB3 SER X 1329 THR X 1343 1 15 HELIX 13 AB4 LEU Y 1125 LYS Y 1132 1 8 HELIX 14 AB5 ASP Y 1164 ASN Y 1171 1 8 HELIX 15 AB6 THR Y 1177 LYS Y 1198 1 22 HELIX 16 AB7 ALA Y 1206 ARG Y 1208 5 3 HELIX 17 AB8 ALA Y 1251 GLN Y 1258 1 8 HELIX 18 AB9 THR Y 1261 THR Y 1278 1 18 HELIX 19 AC1 ASN Y 1288 PHE Y 1290 5 3 HELIX 20 AC2 ASP Y 1291 GLN Y 1298 1 8 HELIX 21 AC3 PRO Y 1309 TRP Y 1320 1 12 HELIX 22 AC4 LYS Y 1323 ARG Y 1327 5 5 HELIX 23 AC5 SER Y 1329 THR Y 1343 1 15 SHEET 1 AA1 4 VAL X1092 THR X1096 0 SHEET 2 AA1 4 HIS X1106 LYS X1110 -1 O VAL X1109 N TYR X1093 SHEET 3 AA1 4 LEU X1154 PRO X1158 -1 O VAL X1155 N LYS X1110 SHEET 4 AA1 4 GLY X1144 CYS X1146 -1 N CYS X1146 O LEU X1154 SHEET 1 AA2 2 CYS X1210 LEU X1212 0 SHEET 2 AA2 2 VAL X1218 VAL X1220 -1 O LYS X1219 N MET X1211 SHEET 1 AA3 4 VAL Y1092 THR Y1096 0 SHEET 2 AA3 4 HIS Y1106 LYS Y1110 -1 O CYS Y1107 N GLY Y1095 SHEET 3 AA3 4 LEU Y1154 PRO Y1158 -1 O VAL Y1155 N LYS Y1110 SHEET 4 AA3 4 GLY Y1144 CYS Y1146 -1 N CYS Y1146 O LEU Y1154 SHEET 1 AA4 2 CYS Y1210 LEU Y1212 0 SHEET 2 AA4 2 VAL Y1218 VAL Y1220 -1 O LYS Y1219 N MET Y1211 CISPEP 1 ARG X 1148 SER X 1149 0 -2.50 CISPEP 2 SER X 1149 GLU X 1150 0 0.00 CISPEP 3 SER X 1152 PRO X 1153 0 -7.95 CISPEP 4 ARG Y 1148 SER Y 1149 0 -3.91 CISPEP 5 SER Y 1149 GLU Y 1150 0 -1.11 CISPEP 6 SER Y 1152 PRO Y 1153 0 -1.62 SITE 1 AC1 11 ALA X1108 PRO X1158 TYR X1159 MET X1160 SITE 2 AC1 11 GLY X1163 ASP X1164 ARG X1208 ASN X1209 SITE 3 AC1 11 ALA X1221 ASP X1222 ALA X1226 SITE 1 AC2 12 VAL Y1092 ALA Y1108 PRO Y1158 TYR Y1159 SITE 2 AC2 12 MET Y1160 GLY Y1163 ASP Y1164 ARG Y1208 SITE 3 AC2 12 ASN Y1209 MET Y1211 ASP Y1222 ALA Y1226 CRYST1 42.853 47.061 81.985 76.96 76.96 90.00 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023336 0.000000 -0.005556 0.00000 SCALE2 0.000000 0.021249 -0.005059 0.00000 SCALE3 0.000000 0.000000 0.012870 0.00000